BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32656971)

  • 1. Diabetes insipidus complicating apoplexy during pregnancy: the potential use of copeptin.
    Bichard LK; Torpy DJ
    Intern Med J; 2020 Jul; 50(7):877-879. PubMed ID: 32656971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid differential diagnosis of diabetes insipidus in a 7-month-old infant: The copeptin approach.
    Vergier J; Fromonot J; Alvares De Azevedo Macedo A; Godefroy A; Marquant E; Guieu R; Tsimaratos M; Reynaud R
    Arch Pediatr; 2018 Jan; 25(1):45-47. PubMed ID: 29241593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus.
    Fenske W; Refardt J; Chifu I; Schnyder I; Winzeler B; Drummond J; Ribeiro-Oliveira A; Drescher T; Bilz S; Vogt DR; Malzahn U; Kroiss M; Christ E; Henzen C; Fischli S; Tönjes A; Mueller B; Schopohl J; Flitsch J; Brabant G; Fassnacht M; Christ-Crain M
    N Engl J Med; 2018 Aug; 379(5):428-439. PubMed ID: 30067922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copeptin-based diagnosis of diabetes insipidus.
    Refardt J; Christ-Crain M
    Swiss Med Wkly; 2020 May; 150():w20237. PubMed ID: 32374887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Copeptin is a new diagnostic biomarker for diabetes insipidus].
    Stankovic J; Rittig S; Jørgensen JOL; Søndergaard E
    Ugeskr Laeger; 2020 Dec; 182(51):. PubMed ID: 33317692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a double-blind, randomized, placebo-controlled study.
    Atila C; Gaisl O; Vogt DR; Werlen L; Szinnai G; Christ-Crain M
    Eur J Endocrinol; 2022 May; 187(1):65-74. PubMed ID: 35521789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copeptin and its role in the diagnosis of diabetes insipidus and the syndrome of inappropriate antidiuresis.
    Refardt J; Winzeler B; Christ-Crain M
    Clin Endocrinol (Oxf); 2019 Jul; 91(1):22-32. PubMed ID: 31004513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of copeptin in the diagnosis of polyuria-polydipsia syndrome.
    Heida JE; Gansevoort RT; van Beek AP
    Lancet; 2020 Jan; 395(10220):267. PubMed ID: 31982061
    [No Abstract]   [Full Text] [Related]  

  • 9. Copeptin in the differential diagnosis of hypotonic polyuria.
    Christ-Crain M; Fenske WK
    J Endocrinol Invest; 2020 Jan; 43(1):21-30. PubMed ID: 31368050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Accuracy of Copeptin in the Differential Diagnosis of Patients With Diabetes Insipidus: A Systematic Review and Meta-analysis.
    Mu D; Ma Y; Cheng J; Qiu L; Chen S; Cheng X
    Endocr Pract; 2023 Aug; 29(8):644-652. PubMed ID: 37225043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gestational diabetes insipidus: Diagnosis and management.
    Ananthakrishnan S
    Best Pract Res Clin Endocrinol Metab; 2020 Sep; 34(5):101384. PubMed ID: 32205050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifactorial diabetes insipidus during pregnancy: a challenging diagnosis.
    Araújo AN; Cunha M; Marques T; Bugalho MJGM
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33722910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes Insipidus: An Update.
    Refardt J; Winzeler B; Christ-Crain M
    Endocrinol Metab Clin North Am; 2020 Sep; 49(3):517-531. PubMed ID: 32741486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a prospective diagnostic study.
    Winzeler B; Cesana-Nigro N; Refardt J; Vogt DR; Imber C; Morin B; Popovic M; Steinmetz M; Sailer CO; Szinnai G; Chifu I; Fassnacht M; Christ-Crain M
    Lancet; 2019 Aug; 394(10198):587-595. PubMed ID: 31303316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome--revisiting the direct and indirect water deprivation tests.
    Fenske W; Quinkler M; Lorenz D; Zopf K; Haagen U; Papassotiriou J; Pfeiffer AF; Fassnacht M; Störk S; Allolio B
    J Clin Endocrinol Metab; 2011 May; 96(5):1506-15. PubMed ID: 21367924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of anti-rabphilin-3A antibodies for diagnosing central diabetes insipidus in the third trimester of pregnancy.
    Sakurai K; Yamashita R; Niituma S; Iwama S; Sugimura Y; Arihara Z; Takahashi K
    Endocr J; 2017 Jun; 64(6):645-650. PubMed ID: 28420857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative Copeptin as a Biomarker for Development of Diabetes Insipidus Following Hypothalamic-Pituitary Surgery.
    Vanasuntorn A; Hansasuta A; Chailurkit LO; Sriphrapradang C
    Endocr Pract; 2021 May; 27(5):463-470. PubMed ID: 33645512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-pituitary surgery copeptin analysis as a 'rule-out' test for post-operative diabetes insipidus.
    Rostom H; Noronha S; Jafar-Mohammadi B; May C; Borg A; Halliday J; Cudlip S; James T; Guha N; Shine B; Pal A
    Endocrine; 2023 Feb; 79(2):358-364. PubMed ID: 36271992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copeptin as a biomarker and a diagnostic tool in the evaluation of patients with polyuria-polydipsia and hyponatremia.
    Christ-Crain M; Morgenthaler NG; Fenske W
    Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):235-47. PubMed ID: 27156761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and differential diagnosis of diabetes insipidus: Update.
    Refardt J
    Best Pract Res Clin Endocrinol Metab; 2020 Sep; 34(5):101398. PubMed ID: 32387127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.